Progressive Multifocal Leukoencephalopathy (PML) is a neurological condition caused by the JC virus, predominantly impacting the central nervous system. Its aggressiveness is evident in patients with immunological compromise, such as those with HIV/AIDS, transplants or those undergoing specific therapies. The objective of this work is to analyze what the most recent literature presents on this topic, considering its relevance today. In this way, we intend to bring to light topics that can improve the life expectancy of these patients." A systematic and quantitative review of the literature was conducted, using platforms such as PubMed, SciELO and Google Scholar until 2023. Exclusion criteria were applied to select retrospective or prospective non-randomized studies for inclusion in the meta-analysis. When the JC virus is reanimated in immunosuppressed hosts, it plays a very important role in the development of PML. Its spectrum of manifestations ranges from demyelination to focal neurological deficits, detectable through examinations imaging techniques such as CT and MRI. Despite efforts, an effective treatment for PML has not yet been identified. Current strategies aim to strengthen the adaptive immune response, such as immediate initiation of antiretroviral therapy in patients with HIV. Research is exploring therapies involving HIV vaccines. dendritic cells and other approaches, but more research is needed. PML remains deadly in most cases. Early detection and a multidisciplinary approach are key to management. Healthcare professionals must be vigilant regarding neurological symptoms in immunosuppressed patients, while awareness and regular monitoring are crucial for patients.
Introduction: Pituitary apoplexy is a potentially fatal disorder due to acute ischemic infarction or hemorrhage of the pituitary gland. The main clinical features of this syndrome are headache, nausea, vomiting, visual impairment, altered mental status and even coma. Methodology: This is a systematic literature review of the quantitative type using the following Keywords: Adeno-Pituitary; Pituitary Apoplexy; Pituitary Neoplasms; Review of Reported Cases. Result: As the primary event involves the adenoma, the syndrome should be termed pituitary tumor apoplexy and not pituitary apoplexy. Although pituitary apoplexy occurs within pituitary adenomas, it can also occur in non-adenomatous or even normal pituitary, especially during pregnancy. Discussion: Although the terminology "subclinical pituitary apoplexy" is widely used to describe anatomopathological evidence of asymptomatic pituitary ischemia or hemorrhage, it is significant to note that pituitary apoplexy is a clinical syndrome and not an anatomopathological definition. Conclusion: although pituitary apoplexy is an uncommon complication of pituitary tumors, it must be recognized as a neuroendocrinological and neurosurgical emergency that requires immediate diagnosis and treatment, individualizing each individual to direct to conservative or more invasive therapies.